| Scientific Imaging Editor
|
more >> |
|
Computercraft seeks an experienced imaging scientist/editor to provide scientific leadership for the development and maintenance of the new imaging agent database at the NIH. The individual will interact with NIH staff scientists and extramural advisors onsite at the NIH campus. This diversified and challenging position requires a PhD (strongly preferred) with postdoctoral laboratory experience or MS degree with exceptional research experience in imaging sciences or highly related field.
|
| Molecular Imaging and Contrast Agent Database
|
more >> |
|
The Molecular Imaging and Contrast Agent Database (MICAD) is an online source of information on in vivo molecular imaging agents based on recommendations from the extramural community.
|
| Letter From The President – May 2010
|
|
One of the ways in which the President of the SRS communicates with the membership is through a through a series of letters published in the society's journal, Nuclear Medicine and Biology, published eight times per year. These messages are made available online as each issue is published and are archived here for future reference.
Read Letter From President Wynn Volkert, PhD (.PDF file)
|
|
| SRS Journal
|
|
 Nuclear Medicine and Biology publishes original research covering all aspects of radiopharmaceutical chemistry: synthesis, radiopharmacy, in vitro and ex vivo testing, and in vivo evaluation of molecular probes for PET, SPECT, planar imaging, and autoradiography.
Full-text articles are available from 1998 to the present. Access to abstracts is complimentary. Access to full text is limited to SRS members and print subscribers.
eManuscript Submission now possible from the the online journal site.
Click here for online access instructions
|
| SRS At A Glance
|
more >> |
|
The SRS is an international society providing academic and intellectual support for radiopharmaceutical science. The SRS is a multidisciplinary professional organization dedicated to the advancement of excellence in education and research in radiopharmaceutical science and in the study and use of radiopharmaceuticals.
The SRS is a 501(c)(6) organization.
|
|
| International Symposium of Technetium and other Radiometals in Chemistry and Medicine (Terachem-2010)
|
more >> |
|
September 8-11, 2010
Bressanone, Italy
The Eighth Terachem-2010 Symposium is co-sponsored by the Society of Radiopharmaceutical Sciences (SRS) and the University of Padova, Department of Pharmaceutical Sciences, and held under the auspice of the Pharmacy Faculty of the University of Padova, SCI, AIMN, GICR, SIFO, and in collaboration with IAFA. The Terachem-2010 Symposium is an outstanding and unique international Symposium that is entirely devoted to radioactive metal chemistry and their use in developing radiotracers for biological and medical studies. The Symposium approaches the multidisciplinary issues related to the development and production of new radiometal-labeled compounds, the synthesis of high specific activity radiotracers, the determination of their structures, and in vitro and in vivo applications in biological and medical systems. The Scientific Program will include both invited presentations and submitted oral and poster sessions focused on the chemistry of technetium and other metals, the
Tc-99m tricarbonyl approach, stability or radiometal-labeled probes, validation of imaging/therapy pairs, quality control of the new radiolabeled drugs, alternatives for Mo-99 production, and imaging and clinical applications. For more information, see Symposium Announcement. The Symposium will encourage participation and interaction among student, post-doctoral fellows and senior scientist through its programming and social functions. SRS sponsored bursaries to support travel of participating students and trainees in the Symposium are available.
Abstract Deadline: April 7, 2010
Abstracts will be submitted to Nuclear Medicine and Biology. Visit the Symposium Website www.terachem2010.com for details.
|
|
